dealREPORTER Says Biogen Unlikely To Buy Elan, Take-Out Premium To Unravel
Short Ideas - Shares of Elan (NYSE:ELN) have been buoyed by two hopeful catalytic events, both of which appear to have gone away. As a result, this stock, … Continue Reading
Read now